VIR
Price:
$7.12
Market Cap:
$980.57M
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with ...[Read more]
Industry
Biotechnology
IPO Date
2019-10-11
Stock Exchange
NASDAQ
Ticker
VIR
According to Vir Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 835.43M. This represents a change of -25.28% compared to the average of 1.12B of the last 4 quarters.
The mean historical Enterprise Value of Vir Biotechnology, Inc. over the last ten years is 2.23B. The current 835.43M Enterprise Value has changed 3.64% with respect to the historical average. Over the past ten years (40 quarters), VIR's Enterprise Value was at its highest in in the March 2021 quarter at 6.10B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
2.23B
Median
1.32B
Minimum
1.17B
Maximum
5.22B
Discovering the peaks and valleys of Vir Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 126.57%
Maximum Annual Enterprise Value = 5.22B
Minimum Annual Increase = -53.75%
Minimum Annual Enterprise Value = 1.17B
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.22B | -53.75% |
2022 | 2.64B | -49.55% |
2021 | 5.22B | 85.18% |
2020 | 2.82B | 126.57% |
2019 | 1.25B | -5.76% |
2018 | 1.32B | 12.85% |
The current Enterprise Value of Vir Biotechnology, Inc. (VIR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.03B
5-year avg
2.63B
10-year avg
2.23B
Vir Biotechnology, Inc.’s Enterprise Value is greater than CureVac N.V. (61.76M), less than Reata Pharmaceuticals, Inc. (6.64B), less than Krystal Biotech, Inc. (5.10B), greater than Propanc Biopharma, Inc. (1.33M), less than IVERIC bio, Inc. (5.13B), less than Blueprint Medicines Corporation (6.36B), greater than Amylyx Pharmaceuticals, Inc. (291.98M), less than Karuna Therapeutics, Inc. (12.43B), less than Day One Biopharmaceuticals, Inc. (963.46M), less than Viking Therapeutics, Inc. (5.81B), less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (222.97M), less than Akero Therapeutics, Inc. (2.00B), less than PTC Therapeutics, Inc. (3.21B), less than Madrigal Pharmaceuticals, Inc. (7.46B),
Company | Enterprise Value | Market cap |
---|---|---|
61.76M | $596.65M | |
6.64B | $6.57B | |
5.10B | $5.48B | |
1.33M | $236.97K | |
5.13B | $5.51B | |
6.36B | $5.98B | |
291.98M | $361.25M | |
12.43B | $12.60B | |
963.46M | $1.38B | |
5.81B | $5.86B | |
915.81M | $794.69M | |
222.97M | $491.80M | |
2.00B | $2.28B | |
3.21B | $3.33B | |
7.46B | $7.58B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vir Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vir Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vir Biotechnology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vir Biotechnology, Inc. (VIR)?
What is the 3-year average Enterprise Value for Vir Biotechnology, Inc. (VIR)?
What is the 5-year average Enterprise Value for Vir Biotechnology, Inc. (VIR)?
How does the current Enterprise Value for Vir Biotechnology, Inc. (VIR) compare to its historical average?